top of page
News​
Nov 26, 2019
Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRTâ„¢ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Aug 22, 2018
Israeli Oncology Company Alpha Tau is Raising Funds
Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars. Israeli oncology company Alpha Tau...
Aug 22, 2018
Israeli Medical Startups Beat a Path to Aging Japan
[..] Another company from Tel Aviv, Alpha Tau Medical, has partnered with Japanese biotechnology startup HekaBio to release radiation...
bottom of page